Chu C - Search Results

1

SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.

He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q. He J, et al. Among authors: chu c. Oncogene. 2020 Mar;39(13):2658-2675. doi: 10.1038/s41388-020-1181-z. Epub 2020 Jan 31. Oncogene. 2020. PMID: 32005974

2

miR-320a is an independent prognostic biomarker for invasive breast cancer.

Yang H, Yu J, Wang L, Ding D, Zhang L, Chu C, Chen Q, Xu Z, Zou Q, Liu X. Yang H, et al. Among authors: chu c. Oncol Lett. 2014 Sep;8(3):1043-1050. doi: 10.3892/ol.2014.2298. Epub 2014 Jun 30. Oncol Lett. 2014. PMID: 25120655 Free PMC article.

3

CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.

Chu CY, Jin YT, Zhang W, Yu J, Yang HP, Wang HY, Zhang ZJ, Liu XP, Zou Q. Chu CY, et al. Int J Oncol. 2016 Jan;48(1):271-80. doi: 10.3892/ijo.2015.3253. Epub 2015 Nov 19. Int J Oncol. 2016. PMID: 26648580

4

EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.

Jin Y, Zhang W, Wang H, Zhang Z, Chu C, Liu X, Zou Q. Jin Y, et al. Among authors: chu c. Oncol Rep. 2016 Feb;35(2):771-8. doi: 10.3892/or.2015.4444. Epub 2015 Nov 25. Oncol Rep. 2016. PMID: 26718028

5

UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.

Jin Y, Zhang W, Xu J, Wang H, Zhang Z, Chu C, Liu X, Zou Q. Jin Y, et al. Among authors: chu c. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12500-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722437 Free PMC article.

6

Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.

He J, Jin Y, Zhou M, Li X, Chen W, Wang Y, Gu S, Cao Y, Chu C, Liu X, Zou Q. He J, et al. Among authors: chu c. Cancer Sci. 2018 Mar;109(3):642-655. doi: 10.1111/cas.13478. Epub 2018 Feb 1. Cancer Sci. 2018. PMID: 29274137 Free PMC article.

7

Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.

Zhang Z, Jin Y, Zhang W, Chu C, Zhang K, Gao X, Zhou J, Zou L, Tang F, Wang H, Zou Q. Zhang Z, et al. Among authors: chu c. J Clin Lab Anal. 2020 May;34(5):e23162. doi: 10.1002/jcla.23162. Epub 2019 Dec 22. J Clin Lab Anal. 2020. PMID: 31867779 Free PMC article.

8

Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients.

Gu S, Chu C, Chen W, Ren H, Cao Y, Li X, He J, Wang Y, Jin Y, Liu X, Zou Q. Gu S, et al. Among authors: chu c. Int J Clin Exp Pathol. 2019 Jun 1;12(6):2009-2021. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934023 Free PMC article.

9

RNA-binding protein QKI suppresses breast cancer via RASA1/MAPK signaling pathway.

Cao Y, Chu C, Li X, Gu S, Zou Q, Jin Y. Cao Y, et al. Among authors: chu c. Ann Transl Med. 2021 Jan;9(2):104. doi: 10.21037/atm-20-4859. Ann Transl Med. 2021. PMID: 33569406 Free PMC article.

10

OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP.

Li X, Wu Z, He J, Jin Y, Chu C, Cao Y, Gu F, Wang H, Hou C, Liu X, Zou Q. Li X, et al. Among authors: chu c. Oncogene. 2021 Jul;40(30):4859-4871. doi: 10.1038/s41388-021-01901-7. Epub 2021 Jun 21. Oncogene. 2021. PMID: 34155345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,849 results

Search Page

Filters